Navigation Links
Novel lung cancer vaccine shows promise in fighting early-stage lung cancer
Date:4/6/2009

MAGE-A3 trial," said Kim. "This is a potential alternative for patients that otherwise would not undergo chemotherapy treatment either because of their tumor stage or other co-morbidities such as their age or other medical problems."

A total of 182 patients with non-small-cell lung cancers were included in the early phase of the study sponsored by GlaxoSmithKline, which is developing the vaccine therapy. All the patients had cancers expressing MAGE-A3, the tumor-specific antigen. After having surgery to remove the tumors, 122 patients were randomly assigned to treatment with the MAGE-A3-targeting vaccine and 60 patients received placebo vaccines. The preliminary research shows that the treatment was well tolerated by patients and the MAGE-A3-treated patients seemed less likely to have recurrences and die from their disease than the placebo-treated patients. Further studies need to be completed to test the safety and efficacy of the vaccine.

Patients were given five injections every three weeks at the beginning of treatment and then eight injections every three months later for a total of 27 months. Earlier phases of the study indicate the immunotherapy treatment was well tolerated by patients.


'/>"/>

Contact: Deborah Song
deb_song@rush.edu
312-942-0588
Rush University Medical Center
Source:Eurekalert

1

GOOD

Page: 1 2

Related biology news :

1. MIT: Novel needle could cut medical complications
2. Ocera Therapeutics licenses novel treatment for acute hepatic encephalopathy from UCLB
3. Novel electric signals in plants
4. Novel veterinary procedure detecting life-threatening injuries touted
5. Forget the freezer: Research suggests novel way to control water behavior
6. Breaking the barrier: Discovery of anti-resistance factors and novel ocean drugs
7. Mayo Clinic researchers suspect a novel gene is causing restless legs syndrome in a large family
8. Fighting obesity and illness with a novel approach to nutrition
9. Novel technology could produce biofuel for around 0.50 a liter ($2.49 a gallon)
10. Novel technology could produce biofuel for around €0.50 a liter ($2.49 a gallon)
11. Studies point to novel target for treating arrhythmias
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/13/2009)... Haven, Conn.A team led by Yale University researchers ... whole blood for the first time. Their findings, ... publication of Nature Nanotechnology , could dramatically ... cancer and other diseases. , The ... of Engineering & Applied Science, and Tarek Fahmy, ...
(Date:12/11/2009)... Malus orientalis species of wild apples that could be ... Middle East and Central Asia. A new study comparing ... varieties from Georgia and Armenia with previously collected varieties ... and establishes a core collection that will make ... research communities. , To identify and record the genetic ...
(Date:12/11/2009)... an associate professor of anthropology at the University of ... Kenya to understand how violence shapes the health of ... of her and her colleagues, research," Documenting the health ... northern Kenya: A conceptual framework," is currently published in ... , in collaboration with the British medical journal the ...
Breaking Biology News(10 mins):Scientists use nanosensors for first time to measure cancer biomarkers in blood 2Understanding apples' ancestors 2UA-led study grapples with health effects of low-intensity warfare 2Yoga Can Ease Lower Back Pain 56417 1Yoga Can Ease Lower Back Pain 56417 2Yoga Can Ease Lower Back Pain 56417 3Reportlinker Adds Gastrointestinal Endoscopy Devices Report 56412 1Reportlinker Adds Gastrointestinal Endoscopy Devices Report 56412 2Reportlinker Adds Gastrointestinal Endoscopy Devices Report 56412 3Reportlinker Adds Gastrointestinal Endoscopy Devices Report 56412 4Reportlinker Adds Gastrointestinal Endoscopy Devices Report 56412 5Reportlinker Adds Gastrointestinal Endoscopy Devices Report 56412 6Reportlinker Adds Gastrointestinal Endoscopy Devices Report 56412 7Reportlinker Adds Gastrointestinal Endoscopy Devices Report 56412 8K State Veterinarian Says Dog Owners Can Make Themselves Their Pets Healthier With Physical Activity Based on Dogs Specific Needs Interests 56409 1K State Veterinarian Says Dog Owners Can Make Themselves Their Pets Healthier With Physical Activity Based on Dogs Specific Needs Interests 56409 2K State Veterinarian Says Dog Owners Can Make Themselves Their Pets Healthier With Physical Activity Based on Dogs Specific Needs Interests 56409 3K State Veterinarian Says Dog Owners Can Make Themselves Their Pets Healthier With Physical Activity Based on Dogs Specific Needs Interests 56409 4
... have identified, for the first time, a molecule that can ... vital role in gene expression and are closely associated with ... a new generation of cancer drugs. , The research ... a particular miRNA, called miR-21, that is implicated in brain ...
... the AVS 55th International Symposium & Exhibition will showcase ... devoted to discoveries on the edge-in a vacuum, at ... to develop new materials and technologies. , AVS ... come from universities, government agencies, and industrial laboratories alike. ...
... are synthetic hormones derived from the human male hormone ... professional baseball and other sports where building muscle strength, ... a sport. A team of researchers has examined the ... after the athletes had ceased to take the drugs. ...
Other Biology News:Scientists identify novel inhibitor of human microRNA 2Scientists identify novel inhibitor of human microRNA 3Save-the-date: Major nanotech, energy, and biomed meeting 2Save-the-date: Major nanotech, energy, and biomed meeting 3Save-the-date: Major nanotech, energy, and biomed meeting 4Anabolic steroids provide a competitive edge in power lifting years after doping has ended 2Anabolic steroids provide a competitive edge in power lifting years after doping has ended 3
(Date:12/11/2009)... Ambit Biosciences Corporation announced today the enrollment and dosing ... Center of the first patient in the ACE ( ... fficacy) Phase 2 pivotal trial in patients with relapsed ... a novel, orally available, potent and highly selective small ... kinase-3 (FLT3) inhibitor. The ACE study is designed ...
(Date:12/11/2009)... the opening of a NEW 2nd North American facility in Marietta, ... logistics center to support Esco,s growth in the North American market, ... laboratory equipment. , ... Hatboro, PA (PRWEB) December 11, ... American facility in Marietta, OH. The facility will serve as a ...
(Date:12/10/2009)... NEW YORK, Dec. 10 With the economy ... Company, Wall Street,s largest, fastest-growing small cap equity research ... of unique investment opportunities within the micro cap market ... on January 11, 2010 at the Grand Hyatt ... cap companies are overlooked and undervalued by much of ...
(Date:12/10/2009)... -- Vivakor, Inc. (OTC Bulletin Board: VIVK) ... an exclusive, $5 million license agreement with ... www.regeneca.com ). The agreement exclusively licenses ... cutting-edge nutraceutical formulation developed by Vivakor and ... by Vivakor for Regeneca. Under the terms ...
Breaking Biology Technology:Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 4Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 5Technology, Biotech, Energy and Transportation Among the Industries to be Featured at Sidoti & Company's First Annual 2010 Micro Cap Conference 2Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 2Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 3
... change as a result of the Sarbanes-Oxley Act ... and companies to continually evaluate their financial controls ... to the technology requirements and information technology (IT) ... technology; however, it is difficult to envision compliance ...
... has an ancient and proud history of interstate sports ... Sometimes, like this past New Years Day, the rivalry ... Wolverines and marijuana have in common? They both get ... be fomenting another interstate rivalry. This one is of ...
... will support American Musical Supplys (AMS) expansion plans ... solutions. AMS , a supplier of musical ... next year and develop business-to-business sales channels using ... , ,AMS was driven to establish a ...
Other Biology Technology:Technology Implications of Sarbanes-Oxley 2Technology Implications of Sarbanes-Oxley 3For Now, Michigan Can Celebrate $150 Million Entrepreneurial VC Fund 2For Now, Michigan Can Celebrate $150 Million Entrepreneurial VC Fund 3For Now, Michigan Can Celebrate $150 Million Entrepreneurial VC Fund 4
...
ID clarifier: platform...
The PROTEAN II xi multi-cell 2-D conversion kit converts the PROTEAN II xi multi-cell to the PROTEAN II XL multi-cell for a wider format cell that accepts 17 to 18 cm IPG strips....
The SVT3-2 diverter valve is a 3-port, 2-position valve for use with the BioLogic DuoFlow system....
Biology Products: